Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir

Immunocompromised patients are at increased risk of complications of influenza virus infection. We report on two critically ill patients on immunosuppressive medication with influenza pneumonia. In both patients, oseltamivir monotherapy did not result in clearance of the virus after 18 and five days...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, Wouter J., Kromdijk, Wiete, van den Broek, Marcel P. H., Haas, Pieter-Jan A., Minnema, Monique C., Boucher, Charles A., de Lange, Dylan W., Wensing, Annemarie M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546743/
https://www.ncbi.nlm.nih.gov/pubmed/26346659
http://dx.doi.org/10.1155/2015/504975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546743/
https://www.ncbi.nlm.nih.gov/pubmed/26346659
http://dx.doi.org/10.1155/2015/504975

Ejemplares similares